Matt Ocko

DCVC

Matt Ocko is co-Managing Partner of DCVC with investments in computational drug discovery, synthetic biology, robotics, applied AI and more. Prior to DCVC, Matt founded and was VP of R&D of Da Vinci Systems. He has a degree in Physics from Yale University, and holds over 50 granted or in-process patents.

SynBioBeta is the leading community of entrepreneurs, investors, policymakers and enthusiasts devoted to the responsible growth of the synthetic biology field. We’re dedicated to telling the stories of the field and companies involved, building their networks, and helping them grow.